Navigation Links
'Reassuring' findings released in national study of influenza vaccine safety in pregnancy
Date:9/23/2013

SAN DIEGO, CA Researchers from Boston University's Slone Epidemiology Center and UC San Diego, in collaboration with the American Academy of Allergy Asthma and Immunology (AAAAI), have found 'reassuring' evidence of the H1N1 influenza vaccine's safety during pregnancy. The national study, which was launched shortly after the pandemic H1N1 influenza outbreak of 2009 and funded by the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA), will be summarized in two companion papers published online this month in the journal, Vaccine.

Despite federal health authorities' recommendations that all pregnant women be vaccinated for influenza in order to avoid serious complications of flu infection, it is estimated that fewer than 50 percent of women follow this advice, largely because they were concerned about the effects flu vaccines might have on the developing baby. Since it was anticipated that the 2009 pandemic H1N1 influenza outbreak could be particularly severe, it was important to gather data on the safety of this vaccine in pregnancy. Therefore, a national study was launched by the Vaccines and Medications in Pregnancy Surveillance System (VAMPSS), a collaboration between investigative teams at Boston University and UC San Diego, and coordinated by the American Academy of Allergy, Asthma and Immunology.

One investigative team, from Boston University, interviewed 4,191 mothers from four regional centers in the U.S. who had either delivered a baby with one of 41 specific birth defects or delivered an infant without defects. They compared the use of influenza vaccine in the two groups during the 2009 - 2011 seasons. In their analysis of birth defects, Dr. Carol Louik, ScD, lead investigator of the BU team, stated "We found no evidence of an increase in risk for the most commonly-occurring specific major birth defects, which were the focus of the study, if a woman received the flu
'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. New findings on tree nuts and health presented at the Experimental Biology Meeting in Boston, Mass.
2. Surprising findings on hydrogen production in green algae
3. Findings to help in design of drugs against virus causing childhood illnesses
4. ACMG releases report on incidental findings in clinical exome and genome sequencing
5. New findings in the search for genetic clues to insulin production
6. The findings between DNMs and autism provides global view of mutability on human diseases
7. Mercury releases contaminate ocean fish: Dartmouth-led effort publishes major findings
8. Verinata Health Announces New Findings At The American Society Of Human Genetics
9. New findings on gene regulation and bone development
10. New findings on protein misfolding
11. Blue Ribbon Panel unveils findings on logistical improvements to support Antarctic science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/6/2015)... JOSE, Calif. , Aug. 6, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... TouchPad technologies on Windows 10. Microsoft leveraged Synaptics, ... to the operating system. Through ... drivers are fully certified with Microsoft,s Precision TouchPad ...
(Date:8/5/2015)... The biosensors market is proving highly attractive ... newer sectors, and development of devices resulting in higher ... seen the entry of multiple participants each year with ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) Recent ... Global Biosensors Market ( http://www.frost.com/nee9 ), finds that ...
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... An international team of scientists, including botanists from the ... can be used to catalogue the world,s plants using a ... classification method that uses a short genetic marker in an ... species. "Barcoding provides an efficient means by which we ...
... forest burnt by wildfires in the United States is set to ... scientists. The study predicts that the worst affected areas ... Mountains, where the area of forest destroyed by wildfire is predicted ... based on a conservative temperature increase of 1.6 degrees Celsius over ...
... Association for the Advancement of Science,s Pacific Division will convene ... from the Western U.S. to share their work. Marking 150 ... Species, the 90th annual meeting will focus on sustainability in ... Sustainability as a way of life, The changing San Francisco ...
Cached Biology News:University of Toronto helps to 'barcode' the world's plants 2Wildfires set to increase 50 percent by 2050 2
(Date:9/1/2015)... Boston, MA (PRWEB) , ... September 01, 2015 ... ... as its new Director of Business Development, Asia Pacific. In this newly-created position, ... expanding the awareness and use of iLab’s suite of tools. This entails not ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... to bring together supply chain risk management and resiliency practitioners with luminaries and ... share best practices, and be recognized for their innovations and performance excellence. At ...
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ( ... "Mexico Biomedical Sensors Market - Growth, Trends & Forecasts ... The Mexico Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:8/31/2015)... , Aug. 31, 2015  RXi Pharmaceuticals Corporation ... on discovering and developing innovative therapies primarily in ... that the 30-day review period following the filing ... ocular indications with the U.S. Food and Drug ... now active. Logo -  ...
Breaking Biology Technology:iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 3Mexico Biomedical Sensors Market Report 2015-2020 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4
... regulatory authorities support filing strategy, SEATTLE, Dec. ... CTIC) reported today that it met with and ... marketing,authorization application (MAA) for XYOTAX(TM) (paclitaxel poliglumex,CT-2103). The ... first quarter,of 2008, earlier than the first half ...
... N.Y. - A new biochip technology could eliminate animal ... curtail its use in the development of new pharmaceuticals, ... at Rensselaer Polytechnic Institute, the University of California at ... most recent discovery will be featured in the online ...
... The first hemostasis kit combines two important surgical tools: ... ... 17 Baxter Healthcare,Corporation today announced the Food and ... sponge, USP and human,thrombin). GELFOAM Plus is the only ...
Cached Biology Technology:Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule 2Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule 3Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule 4Biochip mimics the body to reveal toxicity of industrial compounds 2Biochip mimics the body to reveal toxicity of industrial compounds 3Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit 2Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit 3Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit 4